Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group

scientific article published on 22 December 2013

Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1039756999
P356DOI10.1007/S13277-013-1527-Z
P698PubMed publication ID24363084

P50authorPeng ChenQ57340032
P2093author name stringLin Zhang
Peng Zhang
Bin Zhou
Kui Zhang
Yaping Song
Zhu Zhang
Yan Pu
P2860cites workCould serum visfatin be a potential biomarker for postmenopausal breast cancer?Q60456686
Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trialsQ64112022
Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studiesQ73595220
A study comparing various noninvasive methods of detecting bladder cancer in urineQ77711384
Contemporary management of stage T1 transitional cell carcinoma of the bladderQ77816685
Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesisQ80234311
Cancer incidence in five continents. Volume IXQ83707877
Visfatin, a potential biomarker and prognostic factor for endometrial cancerQ86200525
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factorQ24336391
miRBase: integrating microRNA annotation and deep-sequencing dataQ24615914
Functional aspects of protein mono-ADP-ribosylationQ24675892
Cancer treatment and survivorship statistics, 2012Q27020961
Cancer statistics, 2010Q27860525
The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cellsQ28594408
Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and diseaseQ28611191
Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancerQ30714393
A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridizationQ30827759
Physiological functions of cyclic ADP-ribose and NAADP as calcium messengersQ34192709
RETRACTED: Visfatin: a protein secreted by visceral fat that mimics the effects of insulinQ34377294
Lung cancer signature biomarkers: tissue specific semantic similarity based clustering of digital differential display (DDD) dataQ34466055
Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation studyQ34516108
Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humansQ34768535
The present and future burden of urinary bladder cancer in the worldQ34945758
Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouseQ35018839
Protein deacetylation by sirtuins: delineating a post-translational regulatory program responsive to nutrient and redox stressorsQ36099563
Nampt: linking NAD biology, metabolism and cancerQ37334248
Nampt/PBEF/visfatin and cancerQ37774515
Sirtuins mediate mammalian metabolic responses to nutrient availabilityQ37976307
High visfatin expression in breast cancer tissue is associated with poor survival.Q39501691
Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracilQ39509326
NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress responseQ39642626
FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosisQ40617327
Aromatic amines and cancerQ40894676
Cancer statistics for African Americans, 2013.Q43713119
PIRA PCR designer for restriction analysis of single nucleotide polymorphismsQ43758982
NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction.Q45899490
Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.Q53265518
Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.Q53300738
Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2.Q53573962
SNPStats: a web tool for the analysis of association studies.Q53731244
P433issue5
P304page(s)4031-4040
P577publication date2013-12-22
P1433published inTumor BiologyQ15757842
P1476titleGenetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group
P478volume35

Reverse relations

cites work (P2860)
Q36184224Association of Nicotinamide Phosphoribosyltransferase (NAMPT) Gene Polymorphisms and of Serum NAMPT Levels with Dilated Cardiomyopathy in a Chinese Population
Q28069876Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine
Q35534429Genetic polymorphisms of NAMPT related with susceptibility to esophageal squamous cell carcinoma
Q37718475Genetic variant in visfatin gene promoter contributes to reduced risk of hepatocellular carcinoma in a Chinese population
Q36057124High visfatin expression predicts poor prognosis of upper tract urothelial carcinoma patients
Q38836121Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities
Q37104648Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathy
Q38555243Physiological and pathophysiological roles of NAMPT and NAD metabolism
Q34492819Prognostic value of serum nicotinamide phosphoribosyltransferase in patients with bladder cancer.
Q92461808Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer
Q35959531Visfatin expression and genetic polymorphism in patients with traumatic brain injury

Search more.